We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190 → 205 (+15)

9.43% less ownership

Funds ownership: 64.16% → 54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.2M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
3
BlackRock
BlackRock
New York
+$8.98M
4
GPP
Great Point Partners
Connecticut
+$8.78M
5
GLA
Great Lakes Advisors
Illinois
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
Millennium Management
Millennium Management
New York
-$9.48M
4
Marshall Wace
Marshall Wace
United Kingdom
-$8.68M
5
TCM
Tang Capital Management
California
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
176
Bollard Group
Massachusetts
$11K +$11.8K +1,273 New
KFS
177
Kelly Financial Services
Massachusetts
$10.8K – – –
HWM
178
HighMark Wealth Management
Minnesota
$9K -$1.33K -143 -13%
AF
179
Allworth Financial
California
$9K – – –
Rockefeller Capital Management
180
Rockefeller Capital Management
New York
$9K +$8.44K +910 +910%
BFIM
181
Beese Fulmer Investment Management
Ohio
$9K +$9.28K +1,000 New
RFA
182
Reilly Financial Advisors
California
$9K +$9.28K +1,000 New
RE
183
RBC Europe
United Kingdom
$8.96K – – –
RIM
184
Rockbridge Investment Management
New York
$8K +$8.4K +905 New
BFC
185
Bedel Financial Consulting
Indiana
$6K -$92.8K -10,000 -94%
FHA
186
Flagship Harbor Advisors
Massachusetts
$6K – – –
APA
187
American Portfolios Advisors
New York
$5.6K – – –
PNC Financial Services Group
188
PNC Financial Services Group
Pennsylvania
$4K -$13.9K -1,500 -77%
Daiwa Securities Group
189
Daiwa Securities Group
Japan
$4K – – –
WT
190
Whittier Trust
California
$3K -$464 -50 -12%
BCA
191
Berman Capital Advisors
Georgia
$3K – – –
Northwestern Mutual Wealth Management
192
Northwestern Mutual Wealth Management
Wisconsin
$3K +$2.78K +300 New
GEA
193
Glen Eagle Advisors
New Jersey
$2.29K – – –
BWM
194
Baystate Wealth Management
Massachusetts
$2K – – –
CAC
195
Certified Advisory Corp
Florida
$1K – – –
Fifth Third Bancorp
196
Fifth Third Bancorp
Ohio
$1K – – –
GWM
197
Geneos Wealth Management
Colorado
$1K – – –
IA
198
IFP Advisors
Florida
$1K – – –
PA
199
Parallel Advisors
California
$1K – – –
VFA
200
Valeo Financial Advisors
Indiana
$1K – – –
5 6 7
8
9

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.